Postherpetic Neuralgia (PHN) Clinical Trial
Official title:
Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study
This study is comparing the efficacy and tolerability of Qutenza with that of pregabalin in
patients suffering from peripheral neuropathic pain. Treatment allocation will be to one of
these treatments and the duration of the study will be about 10 weeks (assuming that from
screening to treatment allocation takes 2 weeks). Participants will be asked to complete
questionnaires about various aspects relating to their condition throughout the study.
This study will include subjects suffering from Postherpetic Neuralgia, Peripheral Nerve
Injury or Non Diabetic peripheral polyneuropathy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00407511 -
Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP
|
Phase 4 |